Promis Neurosciences Inc. · NASDAQ:PMN
Wellington Biomedical Innovation Master Investors (Cayman) II, L.P. reported a 7.80% stake in Promis Neurosciences Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 13, 2026
Wellington Biomedical Innovation Master Investors (Cayman) II, L.P. reported a 7.80% stake in Promis Neurosciences Inc., 696,378 shares, as a passive investor on Jun 30, 2026. Filed Aug 13, 2026 (Schedule 13G/A).
- Stake
- 7.80%
- Shares
- 696,378
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Wellington Biomedical Innovation Master Investors (Cayman) II, L.P. | 7.80% | 696,378 |
Source
Related
- Promis Neurosciences Inc.
- Wellington Biomedical Innovation Master Investors (Cayman) II, L.P.
- Promis Neurosciences Inc. shareholders
- Schedule 13G · Wellington Biomedical Innovation Master Investors (Cayman) II, L.P. · Mar 18, 2026
- Schedule 13G/A · Great Point Partners LLC · Aug 14, 2026
- Schedule 13G/A · Wellington Management Group LLP · Aug 13, 2026
- Form 4 · Kaplan Johanne · Aug 7, 2026
- Schedule 13G · Wellington Management Group LLP · May 15, 2026
- Schedule 13G · Great Point Partners LLC · May 15, 2026